vs
Side-by-side financial comparison of Invivyd, Inc. (IVVD) and WEST BANCORPORATION INC (WTBA). Click either name above to swap in a different company.
WEST BANCORPORATION INC is the larger business by last-quarter revenue ($26.9M vs $17.2M, roughly 1.6× Invivyd, Inc.). WEST BANCORPORATION INC runs the higher net margin — 39.2% vs -64.3%, a 103.6% gap on every dollar of revenue. On growth, Invivyd, Inc. posted the faster year-over-year revenue change (24.5% vs 16.6%).
Invivyd, Inc. is a clinical-stage biopharmaceutical company focused on developing broadly neutralizing antibody therapies to prevent and treat serious viral infectious diseases. Its core research and development pipeline targets high-burden respiratory pathogens including respiratory syncytial virus, catering to unmet medical needs of global patient groups.
West Bancorporation Inc. is a regional financial holding company headquartered in the U.S. Midwest, primarily serving markets across Iowa and Minnesota. It provides a full suite of personal and commercial banking services, including deposit accounts, mortgage loans, business lending, and wealth management solutions for individual consumers, small-to-medium enterprises, and local organizational clients.
IVVD vs WTBA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $17.2M | $26.9M |
| Net Profit | $-11.1M | $10.6M |
| Gross Margin | — | — |
| Operating Margin | -73.0% | 50.0% |
| Net Margin | -64.3% | 39.2% |
| Revenue YoY | 24.5% | 16.6% |
| Net Profit YoY | 40.0% | 34.8% |
| EPS (diluted) | $0.02 | $0.61 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $26.9M | ||
| Q4 25 | $17.2M | $24.2M | ||
| Q3 25 | $13.1M | $25.0M | ||
| Q2 25 | $11.8M | $23.8M | ||
| Q1 25 | $11.3M | $23.1M | ||
| Q4 24 | $13.8M | $20.9M | ||
| Q3 24 | $9.3M | $20.3M | ||
| Q2 24 | $2.3M | $19.6M |
| Q1 26 | — | $10.6M | ||
| Q4 25 | $-11.1M | $7.4M | ||
| Q3 25 | $-10.5M | $9.3M | ||
| Q2 25 | $-14.7M | $8.0M | ||
| Q1 25 | $-16.3M | $7.8M | ||
| Q4 24 | $-18.4M | $7.1M | ||
| Q3 24 | $-60.7M | $6.0M | ||
| Q2 24 | $-47.2M | $5.2M |
| Q1 26 | — | 50.0% | ||
| Q4 25 | -73.0% | 39.6% | ||
| Q3 25 | -84.0% | 45.8% | ||
| Q2 25 | -127.8% | 43.4% | ||
| Q1 25 | -149.7% | 43.4% | ||
| Q4 24 | -139.1% | 30.9% | ||
| Q3 24 | -670.0% | 36.6% | ||
| Q2 24 | -2175.2% | 32.6% |
| Q1 26 | — | 39.2% | ||
| Q4 25 | -64.3% | 30.7% | ||
| Q3 25 | -79.7% | 37.3% | ||
| Q2 25 | -124.4% | 33.5% | ||
| Q1 25 | -144.1% | 34.0% | ||
| Q4 24 | -133.5% | 34.0% | ||
| Q3 24 | -653.1% | 29.3% | ||
| Q2 24 | -2086.9% | 26.5% |
| Q1 26 | — | $0.61 | ||
| Q4 25 | $0.02 | $0.44 | ||
| Q3 25 | $-0.06 | $0.55 | ||
| Q2 25 | $-0.12 | $0.47 | ||
| Q1 25 | $-0.14 | $0.46 | ||
| Q4 24 | $-0.14 | $0.41 | ||
| Q3 24 | $-0.51 | $0.35 | ||
| Q2 24 | $-0.40 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $226.7M | $362.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $241.5M | $270.7M |
| Total Assets | $276.9M | $4.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $362.0M | ||
| Q4 25 | $226.7M | $471.1M | ||
| Q3 25 | $85.0M | $232.9M | ||
| Q2 25 | $34.9M | $345.2M | ||
| Q1 25 | $48.1M | — | ||
| Q4 24 | $69.3M | $243.5M | ||
| Q3 24 | $106.9M | — | ||
| Q2 24 | $147.9M | — |
| Q1 26 | — | $270.7M | ||
| Q4 25 | $241.5M | $266.0M | ||
| Q3 25 | $93.1M | $255.1M | ||
| Q2 25 | $42.8M | $240.9M | ||
| Q1 25 | $54.1M | $237.9M | ||
| Q4 24 | $67.5M | $227.9M | ||
| Q3 24 | $83.2M | $235.4M | ||
| Q2 24 | $140.6M | $223.9M |
| Q1 26 | — | $4.0B | ||
| Q4 25 | $276.9M | $4.1B | ||
| Q3 25 | $139.2M | $4.0B | ||
| Q2 25 | $89.1M | $4.1B | ||
| Q1 25 | $103.7M | $4.0B | ||
| Q4 24 | $129.5M | $4.0B | ||
| Q3 24 | $161.9M | $4.0B | ||
| Q2 24 | $177.3M | $4.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.5M | $12.9M |
| Free Cash FlowOCF − Capex | — | $12.4M |
| FCF MarginFCF / Revenue | — | 46.0% |
| Capex IntensityCapex / Revenue | 0.0% | 1.8% |
| Cash ConversionOCF / Net Profit | — | 1.22× |
| TTM Free Cash FlowTrailing 4 quarters | — | $79.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $12.9M | ||
| Q4 25 | $-15.5M | $46.5M | ||
| Q3 25 | $-8.3M | $11.4M | ||
| Q2 25 | $-13.3M | $13.5M | ||
| Q1 25 | $-21.1M | $9.7M | ||
| Q4 24 | $-37.6M | $39.8M | ||
| Q3 24 | $-41.1M | $12.9M | ||
| Q2 24 | $-41.6M | $10.0M |
| Q1 26 | — | $12.4M | ||
| Q4 25 | — | $43.2M | ||
| Q3 25 | — | $10.8M | ||
| Q2 25 | $-13.3M | $12.8M | ||
| Q1 25 | $-21.3M | $8.3M | ||
| Q4 24 | $-37.6M | $13.7M | ||
| Q3 24 | $-41.1M | $7.0M | ||
| Q2 24 | — | $2.7M |
| Q1 26 | — | 46.0% | ||
| Q4 25 | — | 178.3% | ||
| Q3 25 | — | 43.0% | ||
| Q2 25 | -112.9% | 53.6% | ||
| Q1 25 | -188.2% | 35.7% | ||
| Q4 24 | -272.2% | 65.6% | ||
| Q3 24 | -441.6% | 34.2% | ||
| Q2 24 | — | 14.0% |
| Q1 26 | — | 1.8% | ||
| Q4 25 | 0.0% | 13.7% | ||
| Q3 25 | 0.0% | 2.6% | ||
| Q2 25 | 0.1% | 3.2% | ||
| Q1 25 | 1.3% | 6.5% | ||
| Q4 24 | 0.0% | 125.3% | ||
| Q3 24 | 0.1% | 29.4% | ||
| Q2 24 | 0.0% | 37.1% |
| Q1 26 | — | 1.22× | ||
| Q4 25 | — | 6.26× | ||
| Q3 25 | — | 1.23× | ||
| Q2 25 | — | 1.70× | ||
| Q1 25 | — | 1.24× | ||
| Q4 24 | — | 5.61× | ||
| Q3 24 | — | 2.17× | ||
| Q2 24 | — | 1.93× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
